Lipella Pharmaceuticals (NASDAQ:LIPO – Get Free Report) and Chimerix (NASDAQ:CMRX – Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, profitability, dividends, institutional ownership, valuation, analyst recommendations and earnings. Insider and Institutional Ownership 74.3% of Lipella Pharmaceuticals […]
Investment analysts at Maxim Group assumed coverage on shares of Lipella Pharmaceuticals (NASDAQ:LIPO – Get Free Report) in a note issued to investors on Tuesday, Benzinga reports. The brokerage set a “buy” rating and a $2.00 price target on the stock. Maxim Group’s price target indicates a potential upside of 167.85% from the company’s previous […]
Lipella Pharmaceuticals (NASDAQ:LIPO) Stock Price Up 3.5% kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.
Lipella Pharmaceuticals Inc. (NASDAQ:LIPO) Short Interest Update kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.
Lipella Pharmaceuticals (NASDAQ:LIPO – Get Free Report) and InMed Pharmaceuticals (NASDAQ:INM – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, analyst recommendations, valuation, dividends, risk, profitability and institutional ownership. Analyst Recommendations This is a breakdown of […]